Rockwell Medical Presents New Data on Proprietary Iron-Delivery Drug SFP at ... - Stock Markets Review PDF Print
Stock Markets ReviewSFP is a novel, investigational, continuous iron therapy in late-stage clinical development, designed to treat iron deficiency anemia in ESRD patients.

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.